Skip to main content

DRDO's 2-DG Gets DCGI Approval | INMAS develops anti-covid therapeutic application of 2-deoxy-D-glucose drug

Image
By

 DRDO's 2-DG Gets DCGI Approval | INMAS Develops Anti-Covid Therapeutic Application of 2-Deoxy-D-Glucose Drug


DRDO's anti-Covid drug 2-DG

The anti-COVID-19 therapeutic has been developed by DRDO scientists at the Institute of Nuclear Medicine and Allied Sciences (INMAS).

The Drugs Controller General of India (DCGI), a body responsible for approval of licences of drugs in India, has approved the anti-COVID-19 therapeutic developed by Defence Ministry's  Defence Research and Development Organisation (DRDO). The drug, which received the emergency use authorisation on May 1, is called 2-deoxy-D-glucose (2-DG). According to a press release by the Defence Ministry, clinical trials of 2-DG have demonstrated that it helps in faster recovery of patients severely ill with the COVID-19 disease. The drug helps in faster recovery of hospitalised patients by reducing their dependency on oxygen, which can come in handy in these trying times when the country is suffering from an acute shortage of oxygen concentrators. 

Know everything about DRDO's 2-DG drug

The anti-COVID-19 therapeutic has been developed by DRDO scientists at the Institute of Nuclear Medicine and Allied Sciences (INMAS). The drug has been developed in collaboration between DRDO and Dr Reddy’s Laboratories (DRL) in Hyderabad. The drug was ready for clinical trials in April last year after DRDO and INMAS scientists conducted experiments inside the lab and found 2-DG to be safe and effective against the SARS-CoV-2 virus.

Based on the results from the lab experiment, DCGI permitted DRDO to conduct Phase-II clinical trials of the drug. The trials showed 2-DG was effective against the COVID-19 virus and demonstrated signs of recovery in patients. Following the successful Phase-II trials between May and October 2020, the drug was tested again in Phase-IIa and Phase-IIb trials, which were conducted at six and 11 hospitals respectively. Overall the Phase-II trials were conducted on 110 patients. 

The DRDO received approval to conduct Phase-III trials of the drug by DCGI in November 2020. The Phase-II trials were conducted between December 2020-March 2021 at 27 hospitals across India, including in Delhi, Uttar Pradesh, West Bengal, Maharashtra, Gujarat, Tamil Nadu, Telangana, Karnataka, etc. The Phase-III trials were conducted on 220 patients. The results showed faster recovery in patients who took the drug as compared to those who followed just the Standard of Care (SoC). The use of oxygen in patients who took 2-DG declined significantly. 

How to take the drug?

2-DG comes in powder form, which the infected patients can take orally by mixing up the drug in water. The drug, which is akin to a glucose mix, is easy to manufacture and store, which makes it critical at a time when many people are dying because of the lack of oxygen infrastructure for supply and transportation in India. 



New Source : https://www.republicworld.com/india-news/general-news/drdos-2-dg-gets-dcgi-approval-heres-all-you-need-to-know-about-the-anti-covid-19-drug.html


Comments

Post a Comment

Popular posts from this blog

Lab-Grown Blood Stem Cells Produced at Last

By
After 20 years of trying, scientists have transformed mature cells into primordial blood cells that regenerate themselves and the components of blood. The work, described today in Nature, offers hope to people with leukaemia and other blood disorders who need bone-marrow transplants but can’t find a compatible donor. If the findings translate into the clinic, these patients could receive lab-grown versions of their own healthy cells. One team, led by stem-cell biologist George Daley of Boston Children’s Hospital in Massachusetts, created human cells that act like blood stem cells, although they are not identical to those found in nature. A second team, led by stem-cell biologist Shahin Rafii of Weill Cornell Medical College in New York City, turned mature cells from mice into fully fledged blood stem cells. “For many years, people have figured out parts of this recipe, but they’ve never quite gotten there,” says Mick Bhatia, a stem-cell researcher at McMaster University i...
Post a Comment
Read more

Mesentery: New organ discovered inside human body by scientists

By
A new organ has been discovered hiding in plain sight inside the  human body . Known as the mesentery, it was previously thought to be just a few fragmented structures in the digestive system. But scientists have realised it is in fact one, continuous organ.  Although its function is still unclear, the discovery opens up “a whole new area of science,” according to J Calvin Coffey, a researcher at the  University Hospital Limerick  who first discovered it.  "When we approach it like every other organ… we can categorise abdominal disease in terms of this organ," he said.   “Now we have established anatomy and the structure. The next step is the function. If you understand the function you can identify abnormal function, and then you have disease.  “Put them all together and you have the field of mesenteric science.” The research has been published in  The Lancet   medical journa...
Post a Comment
Read more

Stem Cell Therapy for Liver Cirrhosis

By
 Stem Cell Therapy for Liver Cirrhosis Stem cell therapy is a promising area of research for the treatment of liver cirrhosis. Liver cirrhosis is a progressive condition in which the liver becomes scarred and damaged, leading to a loss of liver function. This can be caused by a variety of factors, including chronic alcohol abuse, viral hepatitis, and non-alcoholic fatty liver disease. Stem cells have the potential to regenerate damaged tissues and organs, including the liver. In the case of liver cirrhosis, stem cells can differentiate into liver cells and promote the growth of healthy tissue, thereby restoring liver function. Web: https://www.giostar.com/Therapy/liver-diseases/ Email: stemcells@giostar.com GIOSTAR Ahmedabad:  +91-7043008890 GIOSTAR Bangalore: +91-6366209990 GIOSTAR Chandigarh: +91-9501768105 #STEM #stemcells #therapy #liver #cirrhosis #giostar #livercirrhosis #liverdisease #giostarindia
Post a Comment
Read more